Signaturefd LLC lifted its stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 9.5% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 5,254 shares of the financial services provider’s stock after acquiring an additional 457 shares during the period. Signaturefd LLC’s holdings in CME Group were worth $1,220,000 as of its most recent SEC filing.
A number of other hedge funds also recently made changes to their positions in the stock. Lake Street Advisors Group LLC raised its position in CME Group by 108.7% in the 4th quarter. Lake Street Advisors Group LLC now owns 12,390 shares of the financial services provider’s stock worth $2,949,000 after purchasing an additional 6,453 shares during the period. Meyer Handelman Co. purchased a new position in CME Group in the 4th quarter worth $6,144,000. Spire Wealth Management raised its position in CME Group by 37.4% in the 4th quarter. Spire Wealth Management now owns 1,320 shares of the financial services provider’s stock worth $307,000 after purchasing an additional 359 shares during the period. AEGON ASSET MANAGEMENT UK Plc raised its position in CME Group by 19.3% in the 4th quarter. AEGON ASSET MANAGEMENT UK Plc now owns 326,098 shares of the financial services provider’s stock worth $75,730,000 after purchasing an additional 52,862 shares during the period. Finally, Unified Investment Management purchased a new position in CME Group in the 4th quarter worth $503,000. 87.75% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of equities analysts recently commented on the stock. Citigroup cut shares of CME Group from a “buy” rating to a “neutral” rating and decreased their target price for the stock from $255.00 to $250.00 in a research report on Monday, January 6th. JPMorgan Chase & Co. boosted their price objective on shares of CME Group from $209.00 to $212.00 and gave the company an “underweight” rating in a research report on Thursday, February 13th. Piper Sandler boosted their price objective on shares of CME Group from $250.00 to $258.00 and gave the company an “overweight” rating in a research report on Tuesday, January 7th. Royal Bank of Canada boosted their price objective on shares of CME Group from $235.00 to $269.00 and gave the company a “sector perform” rating in a research report on Thursday, February 13th. Finally, Barclays boosted their price objective on shares of CME Group from $257.00 to $263.00 and gave the company an “equal weight” rating in a research report on Thursday, February 13th. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $238.93.
Insider Buying and Selling
In related news, insider Julie Winkler sold 11,592 shares of the business’s stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the sale, the insider now owns 21,885 shares of the company’s stock, valued at $5,453,085.45. The trade was a 34.63 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Hilda Harris Piell sold 3,984 shares of the business’s stock in a transaction dated Thursday, February 27th. The stock was sold at an average price of $250.47, for a total transaction of $997,872.48. Following the sale, the insider now directly owns 27,046 shares in the company, valued at $6,774,211.62. The trade was a 12.84 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 27,076 shares of company stock valued at $6,871,496 over the last quarter. Corporate insiders own 0.30% of the company’s stock.
CME Group Price Performance
Shares of NASDAQ CME opened at $266.49 on Wednesday. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $266.93. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The company’s 50-day moving average is $244.35 and its 200 day moving average is $233.28. The stock has a market capitalization of $96.03 billion, a P/E ratio of 27.56, a P/E/G ratio of 6.76 and a beta of 0.53.
CME Group (NASDAQ:CME – Get Free Report) last announced its quarterly earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. On average, sell-side analysts expect that CME Group Inc. will post 10.49 earnings per share for the current year.
CME Group Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Friday, March 7th will be paid a dividend of $1.25 per share. The ex-dividend date of this dividend is Friday, March 7th. This represents a $5.00 annualized dividend and a yield of 1.88%. This is a positive change from CME Group’s previous quarterly dividend of $1.15. CME Group’s payout ratio is presently 51.71%.
CME Group declared that its Board of Directors has initiated a stock repurchase program on Thursday, December 5th that permits the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization permits the financial services provider to reacquire up to 3.4% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s board believes its stock is undervalued.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More
- Five stocks we like better than CME Group
- ESG Stocks, What Investors Should Know
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- What Does a Stock Split Mean?
- 3 Must-Own Stocks to Build Wealth This Decade
- What is a Death Cross in Stocks?
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.